TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
3H Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
367
|
331 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
67
|
18 | |
| EBITDA |
69
|
21 | |
| Total assets |
287
|
320 | |
| Current assets |
278
|
310 | |
| Current liabilities |
61
|
75 | |
| Equity capital |
209
|
229 | |
| - share capital |
8
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
72.8%
|
71.6% | |
| Turnover per employee |
184
|
166 | |
| Profit as a percentage of turnover |
18.3%
|
5.4% | |
| Return on assets (ROA) |
23.3%
|
5.6% | |
| Current ratio |
455.7%
|
413.3% | |
| Return on equity (ROE) |
32.1%
|
7.9% | |
| Change turnover |
69
|
107 | |
| Change turnover % |
-34%
|
23%
|
47% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.